Comments
Loading...
Ascendis Pharma (ASND) Forecast
NewsEarningsAscendis Pharma (ASND) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAscendis Pharma (NASDAQ:ASND) Stock Quotes, Forecast and News Summary
Ascendis Pharma Stock (NASDAQ: ASND) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ascendis Pharma (ASND) stock?
You can purchase shares of Ascendis Pharma (NASDAQ:ASND) through any online brokerage.
Who are Ascendis Pharma (ASND) competitors?
Other companies in Ascendis Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the forecast, or price target, for Ascendis Pharma (ASND) stock?
Ascendis Pharma has a consensus price target of $179.17.
What is the current price for Ascendis Pharma (ASND)?
The stock price for Ascendis Pharma (NASDAQ: ASND) is $123.2 last updated November 20, 2024 at 8:15 AM EST.
Does Ascendis Pharma (ASND) pay a dividend?
There are no upcoming dividends for Ascendis Pharma.
When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?
Ascendis Pharma’s Q4 earnings are confirmed for Wednesday, February 5, 2025.
Is Ascendis Pharma (ASND) going to split?
There is no upcoming split for Ascendis Pharma.
What sector and industry does Ascendis Pharma (ASND) operate in?
Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.